EUDAMED's Slow Rollout Is Finally Forcing Medical Device Teams to Get Ready

Introduction

If you work in medical device regulatory affairs in Europe, you have heard the name for years without necessarily having to use the system every day: EUDAMED, the European Database on Medical Devices. It was written into the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) as the single place where device registrations, economic operator information, notified body certificates, clinical investigations, and vigilance reports would all live. It was also, for years, the regulation's most famous unfinished promise, repeatedly delayed while the European Commission worked through the technical and legal complexity of building a pan-EU database that has to reconcile data from dozens of national authorities, thousands of manufacturers, and several different device classifications at once.

That slow build-out is not a side story anymore. Module by module, EUDAMED is becoming something regulatory teams actually have to use, not just watch from a distance. And every time a module moves from optional to mandatory, it creates real work: data entry, data governance, internal process changes, and in a growing number of companies, dedicated headcount. This article walks through what EUDAMED actually does, why its rollout has taken this long, and what the shift to mandatory use is creating for people who work in medical device regulatory affairs.

What EUDAMED Actually Covers

EUDAMED is not one registration form. It is built from six interlinked modules, each covering a different slice of the device lifecycle:

• Actor registration — manufacturers, authorized representatives, importers, and system/procedure pack producers register and receive a Single Registration Number (SRN).
• UDI/device registration — Basic UDI-DI and UDI-DI records, linking a device's unique identifier to its regulatory and technical information.
• Notified bodies and certificates — tracking which notified body issued which certificate, for which device, and its current status.
• Clinical investigations and performance studies — the registry of device clinical investigations and IVD performance studies conducted in the EU.
• Vigilance and post-market surveillance — serious incident reports, field safety corrective actions, and trend reporting.
• Market surveillance — the module competent authorities use to coordinate oversight and inspections.

Taken together, these modules are meant to give regulators, notified bodies, and eventually the public a single, searchable view of what devices are on the EU market, who is responsible for them, and what has gone wrong with them. For a manufacturer, that means data that used to live in internal spreadsheets, regulatory information management (RIM) systems, or paper files now has to be structured, submitted, and kept current in a format the Commission controls.

Why the Rollout Has Taken So Long

EUDAMED was supposed to be fully operational years before it actually became mandatory for any module. The reasons are not mysterious, even if they have been frustrating to live with. Each module has to interoperate with national databases and existing notified body systems that were never built to a common standard. Data quality and deduplication across thousands of manufacturers and legacy device records is a genuinely hard problem — the same device family can show up under different names, different authorized representatives, or different legacy registrations in different member states. And because EUDAMED data eventually becomes publicly searchable, the Commission has had to get the governance, validation, and audit of each module right before switching on mandatory use, rather than shipping something fast and fixing it live.

The approach that emerged is a module-by-module rollout: each module is independently audited and confirmed functional before the Commission sets a date for mandatory use, rather than the "flip the switch on everything at once" plan the regulation originally implied. Actor registration was the first module to move from voluntary to effectively required, since an SRN is now a practical prerequisite for other registrations and for notified body work. Other modules are following on their own audited timelines. If you need the current state of play for a specific module, the European Commission's EUDAMED pages are the authoritative source — the mandatory-use dates are the kind of detail that is worth checking fresh rather than relying on a general-knowledge summary, because they move.

The Work This Is Creating

None of this is abstract to the people doing the job. A few patterns are showing up across device companies, from large multinational manufacturers down to smaller firms managing their first CE-marked product:

• SRN and actor data ownership. Someone has to be the person who keeps actor registration data accurate across every legal entity a company uses to place devices on the EU market — including when a company restructures, acquires another manufacturer, or changes authorized representatives.
• UDI data governance. Basic UDI-DI and UDI-DI records have to match what is on labeling, in technical documentation, and in the company's own product master data. Mismatches are a common source of rework, and larger device portfolios make this a standing task rather than a one-time project.
• Cross-checking against notified body certificate data. As the certificates module matures, regulatory teams increasingly need to confirm their own certificate records line up with what their notified body has submitted, rather than assuming the two systems agree.
• Vigilance workflow migration. As vigilance reporting moves further into EUDAMED, the people who used to file field safety corrective actions and incident reports through national portals or ad hoc processes have to learn a new system without missing regulatory deadlines in the meantime.

In job postings, this shows up as "EUDAMED experience," "UDI database management," or "EU device registration data management" appearing as explicit, named skills — sometimes in roles that didn't used to call out a specific database by name. Some companies are building dedicated regulatory operations or regulatory data roles to own this work full time, especially manufacturers with large device portfolios across many classifications. Others are folding it into existing device regulatory affairs specialist roles, which means those specialists need to be comfortable with structured data entry and data governance in addition to the more familiar technical-file and submission work.

How This Changes the Relationship With Notified Bodies and Authorities

Before EUDAMED, a lot of the information regulators and notified bodies needed about a given device lived in scattered places: a technical file here, a certificate database maintained by an individual notified body there, vigilance reports routed through whichever national competent authority happened to receive them. That fragmentation gave manufacturers a certain amount of practical slack — a gap in one system rarely surfaced immediately in another. A unified, cross-referenced database closes that slack. Once device registration, certificate status, and vigilance history sit in the same system, inconsistencies that used to pass unnoticed become visible to anyone who queries the record, including competent authorities doing market surveillance.

That is not a bad thing for the field as a whole — one of the stated goals of EUDAMED is to give authorities and notified bodies a faster, more reliable way to spot problem devices and act on them before harm spreads across multiple countries. But it does raise the bar for the quality of data regulatory teams submit. A registration that is "close enough" in a spreadsheet is a liability once it sits in a database a notified body auditor can pull up during a routine review. Regulatory affairs professionals who have internalized that shift — who treat EUDAMED submissions with the same rigor as a technical file, rather than as an administrative afterthought — are the ones building a track record their employers notice.

What This Means If You Want to Build the Skill

You do not need to wait for a module to become mandatory to get useful experience with it. Actor registration is already something most device companies with EU operations have had to do, and UDI assignment is tied closely to labeling work many regulatory affairs professionals already touch. If your current employer has not yet needed to engage deeply with EUDAMED, ask whether you can shadow or support the person who owns SRN and UDI data — it is a concrete, learnable skill rather than a vague interest area, and the EU's own guidance documents on each module are detailed enough to self-study from.

It is also worth being honest about what this niche is and is not. EUDAMED familiarity is unlikely to be the center of a long career the way, say, submissions strategy or clinical evaluation work can be. But as a specific, in-demand data and process skill layered onto a device regulatory affairs background, it is a reasonable way to make a resume stand out for EU-facing roles right now, and the underlying skill — structured regulatory data governance across a multi-system landscape — holds up well beyond EUDAMED itself.

Conclusion

EUDAMED's long, module-by-module rollout has made it easy to treat as background noise — a system that is always "coming soon" rather than something to plan around. That is changing. Each module that moves to mandatory use turns a compliance requirement into day-to-day regulatory work, and companies are responding by building out the people and processes to do it well. For device regulatory affairs professionals, understanding what each module actually requires, and being able to speak to hands-on experience with actor registration or UDI data management, is a practical way to stay ahead of a system that is finally becoming real.